Patent · US Expired

Arylalkyl-thiadiazinones

US5747489A · kind A · utility

3Cited by

3References

8Claims

0Family size

Assignee

Merck Patent GmbH · DE

Inventors

Rochus Jonas · Darmstadt, DE
Michael Wolf · Darmstadt, DE
Michael Klockow · Lutherstadt Eisleben, DE

Key dates

Filing date	Jan 26, 1996
Grant date	May 5, 1998
Priority date	—
Expiry date	Jan 26, 2016

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Arylalkyl-thiadiazinone derivatives of the formula I ##STR1## and physiologically unobjectionable salts thereof in which R.sup.1, R.sup.2, R.sup.3, R.sup.4, R.sup.5 and Q have the meanings given in claim 1, exhibit phosphodiesterase IV inhibition and can be used for the therapy of asthmatic disorders.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.